Eclipsemed establishes new manufacturing and international sales entity

Eclipsemed Ltd., a leading national supplier of advanced medical and aesthetic equipment, has announced the formation of Eclipse Global, its new manufacturing and international sales entity. Eclipse Global has acquired the controlling assets of Enlighten Medical Technologies, an Amsterdam-based company which manufacturers intense pulsed light and various laser technologies.

Tom O'Brien, CEO of Eclipsemed will also assume the role of Chief Executive Officer for Eclipse Global. Both companies will be headquartered in Dallas, Texas. Joining Eclipse Global as Chairman of the Board is Raz Avner, former CEO of Lumenis from 2003-2007. Ron Zakai, founder of Enlyten Medical Technologies, will join Eclipse Global as a consultant for the company.

"Eclipse, as a result of the Enlyten acquisition, is now positioned to control its destiny like never before," says Tom O'Brien CEO Eclipsemed and Eclipse Global. "Instead of waiting for the next big idea to come our way, we look forward to delivering those ideas from within, utilizing our talented organization. Eclipse is pleased to have moved successfully from a regional to a national distributor. We look forward to the future and establishing our goal of becoming a leading global aesthetic device manufacturer."

"As a research and development based company, Enlyten found itself with a significant portfolio of products and limited capacity for sales distribution," says Ron Zakai, Enlyten founder. "After researching distribution options, we were pleased to have found Eclipse, based in the United States. To duplicate the infrastructure Eclipse had already created would have required an intense investment for Enlyten. With such a realization in mind, both companies concluded our mutual strengths would be enhanced by becoming one. We are very excited to be a part of the Eclipse Global team as we prepare for several product launches in 2010."

Source:

Eclipsemed Ltd.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
UC San Diego receives $12.25 million NIH grant to improve epilepsy treatment